Disciplines:

Nursing

Hours: 25 Contact Hours (25 Pharm Hours)
Item#: NBT25

 

Choose the best WS365 Online Nursing Membership for you:
Basic Membership – Access to 1-15 hour courses
PREMIUM Membership – Access to ALL nursing course

Pharmacology Bundle


Reg. Prices
Just $78.95
Item # NBT25
New
When available, the Online Course format is included with the hard copy, eBook, or audio book formats!

Cardiovascular disease is highly prevalent among the adult population. Nurses who are prescribing medications and those who care for these patients must maintain current knowledge of relevant medications.   

This CE bundle includes three high-level courses that also qualify for pharmacology hours: nursing pharmacology, cardiovascular pharmacology, and anticoagulant, antiplatelet, and thrombolytic therapies.

This product includes the following courses:
Click on the title to see more and read the course

Nursing Psychopharmacology

Price: $32.95  
Item # N1751  

Release Date: December 27, 2016

Expiration Date: December 31, 2019

 

Studies show that millions of people each year in the United States are affected by mental illness, however only about half of these receive treatment. Approximately 40 million people (18%) of the population suffer from an anxiety disorder annually. The prevalence of bipolar disorders is projected to be at 2.6% of the adult population and 11.2% for 13 to 18 year olds.  Depressive conditions are among the most frequently occurring mental health disorders in this country, 6.6% of adults aged 18 or older had a major depressive episode in 2014. The lifetime prevalence of schizophrenia is calculated to be about 1% of the population.

The National Center for Health Workforce Analysis estimates that the increase in supply of primary care physicians will fall short of the increased demand for primary care providers by 2025. Additionally, the NCHWA has estimated that the number of nurse practitioners providing primary care services will increase by 30% by the year 2020.

With the growing number of nurse practitioners entering the healthcare field as primary care providers, there is a demonstrated need for education on the ever-increasing number of new pharmaceutical agents available, to treat the wide spectrum of mental illness. This course addresses these needs by providing up-to-date information and a variety of case studies to illustrate practical application of the learning content.


This course should not be taken in conjunction with N1692 - Antidepressants, 2nd Edition, N1710 - Differentiating Antipsychotics: An Overview of Properties Impacting Drug Selection, or N1713 - Anxiolytics and Traditional Mood Stabilizers.


Kentucky APRNs - fuliflls pharmacology requirement

Cardiovascular Pharmacology, 3rd Edition

Price: $26.95  
Item # N1744  

Release Date: December 27, 2016

Expiration Date: December 31, 2019

 

According to data from the Center for Disease Control, 610,000 people die from heart disease in the United States annually.  One in every four deaths is due to cardiovascular disease. There are also 12 million yearly visits to physician’s offices and close to 4 million hospital discharges for cardiovascular disease. Treatment of cardiovascular disease and monitoring for therapeutic efficacy and side effects of the drugs used require a sound knowledge of the pharmacology of these agents.

Ongoing education is needed to keep pace with these evolving changes and to equip nursing professionals with the necessary knowledge and skills to implement the most recent advances in treatment. Nurses have an important responsibility in caring for patients who are receiving these medications. Knowledge of cardiovascular medications, their effects on the body, and their administration; assessment of therapeutic and adverse effects; and patient education are essential. The purpose of this course is to provide an overview of cardiovascular pharmacology. With an ever-increasing number of patients living longer, quality nursing care for those receiving drugs for cardiovascular disease will make this knowledge critical. 

 

 

Kentucky APRNs - fulfills pharmacology requirement

 

 

Anticoagulant, Antiplatelet, and Thrombolytic Therapies: Implications for Advanced Practice Nursing

Price: $32.95  
Item # N1752  

Release Date: December 27, 2016

Expiration Date: December 31, 2019

 

Cardiovascular disease (CVD) is the leading cause of death in the United States. Despite a decline in the death rate in 2013, nearly 1 in 3 deaths were attributed to CVD. Anticoagulant, antiplatelet, and thrombolytic medications are commonly utilized in the prevention and management of many common medical conditions, including cardiovascular disease (stable and unstable angina), ST-elevation myocardial infarction, percutaneous coronary interventions that include stent placement, cardiac dysrhythmias (atrial fibrillation), acute arterial occlusion, peripheral arterial disease, deep vein thrombosis, pulmonary embolism, and ischemic stroke.  

Evidence-based nursing practice requires that nurses have the necessary knowledge base to assure competent and safe nursing care. The Joint Commission (2012) addresses the issue of patient safety within the context of anticoagulation therapy in National Patient Safety Goal 03.05.01, which advises healthcare providers to “reduce the likelihood of patient harm associated with the use of anticoagulant therapy.”

This course provides information on oral anticoagulants, with an emphasis on the novel oral anticoagulants, parenteral anticoagulants, antiplatelets, and thrombolytics. Their indications for treatment of cardiovascular disorders including atrial fibrillation, venous thromboembolism, acute coronary syndrome, heparin induced thrombocytopenia, acute ischemic stroke, acute myocardial infarctions and acute pulmonary embolism is review. In addition, monitoring guidelines and patient counseling is discussed.  The need for healthcare providers to understand the pharmacokinetics, pharmacodynamics, and pharmacotherapeutic considerations is imperative to achieve optimal patient outcomes.

 

This course should not be taken in conjunction with N1712 - Parenteral Anticoagulants: Implications for Patient Management, N1718 - Oral Anticoagulant Therapy: Implications for Patient Management, N1743 - Antiplatelet Therapy: Implications for Advanced Practice Nursing, or N1749 - Thrombolytic Therapy: Implications for Advanced Practice Nursing.

Kentucky APRNs - fulfills pharmacology requirement

 

Want more choices?
Want more choices?